Literature DB >> 23978520

miR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein.

Yang Zhou1, Mingxia Xiong1, Li Fang1, Lei Jiang1, Ping Wen1, Chunsun Dai1, Chen-Yu Zhang2, Junwei Yang3.   

Abstract

Renal fibrosis is inevitably progressive no matter what the initial insult is or whether the insult persists. In an experimental fibrosis model induced by unilateral ureteral obstruction, the accelerated pathological changes could hardly be explained by aggravated pressure caused by hydronephrosis after ligation. Moreover, at the initial stage, tubular phenotype transition and matrix deposition in obstructive kidneys are always local and scattered; however, these renal lesions expand and progress with time. In this study, cultured recipient tubular cells underwent phenotype transition after incubation with conditioned media derived from transforming growth factor-β1-treated donor tubular cells. Thus, it is reasonable to speculate that some secretable molecules from injured tubules contribute to the progression of renal fibrosis. Herein, we report that secreted miRNA-21 (miR-21) can serve as the molecule mediating intercellular communication. miR-21 was packaged into microvesicles, which enter and deliver miR-21 into recipient tubular cells, and exogenous miR-21 enhances Akt signaling by target depression of phosphatase and tensin homolog (PTEN) protein, and promotes tubular phenotype transition. These results demonstrate that tubular cells can secrete miR-21 and deliver it into recipient tubules by microvesicles, where the exogenous miR-21 can target PTEN protein and enhance Akt signaling in recipient cells. Microvesicle-mediated delivery of miR-21 among tubular epithelial cells might shed new light on the mechanism of progressive renal fibrosis.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23978520     DOI: 10.1016/j.ajpath.2013.06.032

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.

Authors:  Rohan Samarakoon; Sevann Helo; Amy D Dobberfuhl; Nidah S Khakoo; Lucas Falke; Jessica M Overstreet; Roel Goldschmeding; Paul J Higgins
Journal:  J Pathol       Date:  2015-04-27       Impact factor: 7.996

2.  Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation.

Authors:  Lin-Li Lv; Ye Feng; Yi Wen; Wei-Jun Wu; Hai-Feng Ni; Zuo-Lin Li; Le-Ting Zhou; Bin Wang; Jian-Dong Zhang; Steven D Crowley; Bi-Cheng Liu
Journal:  J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 10.121

3.  Renal Tubular Cell-Derived Extracellular Vesicles Accelerate the Recovery of Established Renal Ischemia Reperfusion Injury.

Authors:  Jesus H Dominguez; Yunlong Liu; Hongyu Gao; James M Dominguez; Danhui Xie; K J Kelly
Journal:  J Am Soc Nephrol       Date:  2017-07-26       Impact factor: 10.121

4.  Extracellular vesicles in kidneys and their clinical potential in renal diseases.

Authors:  Sul A Lee; Chulhee Choi; Tae-Hyun Yoo
Journal:  Kidney Res Clin Pract       Date:  2021-04-13

5.  Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease.

Authors:  Ayumi Usui-Ouchi; Yasuo Ouchi; Masatoshi Kiyokawa; Toshiro Sakuma; Rei Ito; Nobuyuki Ebihara
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

6.  Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

Authors:  Thomas Lener; Mario Gimona; Ludwig Aigner; Verena Börger; Edit Buzas; Giovanni Camussi; Nathalie Chaput; Devasis Chatterjee; Felipe A Court; Hernando A Del Portillo; Lorraine O'Driscoll; Stefano Fais; Juan M Falcon-Perez; Ursula Felderhoff-Mueser; Lorenzo Fraile; Yong Song Gho; André Görgens; Ramesh C Gupta; An Hendrix; Dirk M Hermann; Andrew F Hill; Fred Hochberg; Peter A Horn; Dominique de Kleijn; Lambros Kordelas; Boris W Kramer; Eva-Maria Krämer-Albers; Sandra Laner-Plamberger; Saara Laitinen; Tommaso Leonardi; Magdalena J Lorenowicz; Sai Kiang Lim; Jan Lötvall; Casey A Maguire; Antonio Marcilla; Irina Nazarenko; Takahiro Ochiya; Tushar Patel; Shona Pedersen; Gabriella Pocsfalvi; Stefano Pluchino; Peter Quesenberry; Ilona G Reischl; Francisco J Rivera; Ralf Sanzenbacher; Katharina Schallmoser; Ineke Slaper-Cortenbach; Dirk Strunk; Torsten Tonn; Pieter Vader; Bas W M van Balkom; Marca Wauben; Samir El Andaloussi; Clotilde Théry; Eva Rohde; Bernd Giebel
Journal:  J Extracell Vesicles       Date:  2015-12-31

Review 7.  Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.

Authors:  Arash Aghajani Nargesi; Lilach O Lerman; Alfonso Eirin
Journal:  Stem Cell Res Ther       Date:  2017-12-04       Impact factor: 6.832

8.  Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis.

Authors:  Congcong Chen; Chaosheng Lu; Yan Qian; Haiyan Li; Yi Tan; Lu Cai; Huachun Weng
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

Review 9.  Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics.

Authors:  David R Brigstock
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

10.  miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.

Authors:  Ryuji Morizane; Shizuka Fujii; Toshiaki Monkawa; Ken Hiratsuka; Shintaro Yamaguchi; Koichiro Homma; Hiroshi Itoh
Journal:  Sci Rep       Date:  2014-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.